13 C NMR (100 MHz, CDCl 3 ): (ppm): 159.83, 151.91, 144.77, 143.46, 143.43, 143.25, 139.96, 133.16, 131.98, 131.89, 130.99, 129.54, 128.76, 128.45, 128.09, 127.80, 127.77, 114.73, 113.52, 81.98
A research study to look into the long-term effect on weight loss of CagriSema in people with obesity (NCT06780449) Summary: This is an ongoing Phase 3 trial (as of current knowledge) designed to evaluate the long-term efficacy and safety of once-weekly CagriSema in people living with obesity
The pediatricians participating in this study could confirm continuation, or not, into the study after the clinical laboratory results were available
Prescription Drug Addiction Our drug and alcohol rehab also assists individuals suffering from prescription drug abuse